UpdatesPress Release
CORONA Remedies reports Q1 FY27 revenue up 21.9% to ₹422.4 Cr and PAT up 30.1% to ₹60.1 Cr.
CORONA Remedies LimitedCORONA · Filed with the exchange
Company is the fastest growing among top 30 IPMs and ranks 26th.
New EU-GMP female hormone plant operational.
No comments yet. Be the first.